211 related articles for article (PubMed ID: 34556636)
1. Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone.
He Y; Cheng D; Lian C; Liu Y; Luo W; Wang Y; Ma C; Wu Q; Tian P; He D; Jia Z; Lv X; Zhang X; Pan Z; Lu J; Xiao Y; Zhang P; Liang Y; Yang Q; Hu G
Cell Death Dis; 2021 Sep; 12(10):868. PubMed ID: 34556636
[TBL] [Abstract][Full Text] [Related]
2. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
[TBL] [Abstract][Full Text] [Related]
3. Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner.
Guo JY; Hsu HS; Tyan SW; Li FY; Shew JY; Lee WH; Chen JY
Oncogene; 2017 Apr; 36(17):2457-2471. PubMed ID: 27819672
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
[TBL] [Abstract][Full Text] [Related]
5. Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer.
Zhu Y; Lam AKY; Shum DKY; Cui D; Zhang J; Yan DD; Li B; Xu WW; Lee NPY; Chan KT; Law S; Tsao SW; Cheung ALM
Theranostics; 2021; 11(6):2722-2741. PubMed ID: 33456569
[No Abstract] [Full Text] [Related]
6. The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2.
Manou D; Golfinopoulou MA; Alharbi SND; Alghamdi HA; Alzahrani FM; Theocharis AD
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672477
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption.
Xu L; Luo J; Jin R; Yue Z; Sun P; Yang Z; Yang X; Wan W; Zhang J; Li S; Liu M; Xiao J
Mol Cancer Ther; 2016 May; 15(5):854-65. PubMed ID: 26861247
[TBL] [Abstract][Full Text] [Related]
8. Stromal Cell-Derived CCL20 Promotes Tumor Progression and Osteolysis in Giant Cell Tumor of Bone.
Zhao C; Wang D; Tang L; Zhang Z; Li S; Qian M; Wu Z; Zhou W; Liu M; Luo J; Liu T; Li Z; Xiao J
Cell Physiol Biochem; 2018; 51(5):2472-2483. PubMed ID: 30537747
[TBL] [Abstract][Full Text] [Related]
9. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
11. Serglycin as part of IL-1β induced inflammation in human chondrocytes.
Scuruchi M; D'Ascola A; Avenoso A; Mandraffino G G; Campo S S; Campo GM
Arch Biochem Biophys; 2019 Jul; 669():80-86. PubMed ID: 31145901
[TBL] [Abstract][Full Text] [Related]
12. Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.
Purushothaman A; Toole BP
J Biol Chem; 2014 Feb; 289(9):5499-509. PubMed ID: 24403068
[TBL] [Abstract][Full Text] [Related]
13. Denosumab Induces Neoplastic Stromal Cell Apoptosis
Chen X; Ye F; He H; Chen G; Chen Z; Ye E; He B; Yang Y; Zhang J
Curr Cancer Drug Targets; 2024; 24(5):565-578. PubMed ID: 37961860
[TBL] [Abstract][Full Text] [Related]
14. Biological characteristics of a novel giant cell tumor cell line derived from spine.
Zhou Z; Li Y; Xu L; Wang X; Chen S; Yang C; Xiao J
Tumour Biol; 2016 Jul; 37(7):9681-9. PubMed ID: 26801673
[TBL] [Abstract][Full Text] [Related]
15. Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib.
Liu L; Aleksandrowicz E; Fan P; Schönsiegel F; Zhang Y; Sähr H; Gladkich J; Mattern J; Depeweg D; Lehner B; Fellenberg J; Herr I
Cell Death Dis; 2014 Oct; 5(10):e1471. PubMed ID: 25321478
[TBL] [Abstract][Full Text] [Related]
16. Serglycin is involved in inflammatory response in articular mouse chondrocytes.
D'Ascola A; Scuruchi M; Avenoso A; Bruschetta G; Campo S; Mandraffino G; Campo GM
Biochem Biophys Res Commun; 2018 May; 499(3):506-512. PubMed ID: 29588174
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
18. ALCAM
Zhou Z; Li Y; Wang X; Hu J; Kuang M; Wang Z; Li S; Xu W; Xiao J
Cell Death Dis; 2018 Feb; 9(3):299. PubMed ID: 29463803
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]